unknown
Stage
About
Focal Biosciences develops a platform and pipeline leveraging chromatin fingerprint technology and AI to discover drugs that reprogram cells at the epigenetic level to treat and potentially reverse chronic and age-related diseases, focusing initially on fibrotic diseases.
Explore Focal Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.